Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
Anti-TNFalpha drugs are currently used in the treatment of patients with Crohn's disease. Studies have reported neurological side effects occurring after anti-TNFalpha treatment, including infliximab-induced complications.